Conjugation Of EGCG And Chitosan NPs As A Novel Nano-Drug Delivery System
Received 10 June 2019
Accepted for publication 4 September 2019
Published 4 October 2019 Volume 2019:14 Pages 8033—8046
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. Anderson Oliveira Lobo
Abdel-Majeed Safer,1 Stefano Leporatti,2 Jacquilion Jose,3 Mahmoud S Soliman4
1Department of Biological Sciences, Faculty of Science, Kuwait University, Kuwait City, Kuwait; 2CNR Nanotec, Istituto di Nanotecnologia, Lecce 73100, Italy; 3Nanoscopy Science Center, Faculty of Science, Kuwait University, Kuwait City, Kuwait; 4Nanotechnology Research Facility, Faculty of Engineering and Petroleum, College of Engineering and Petroleum, Kuwait University, Kuwait City, Kuwait
Correspondence: Abdel-Majeed Safer
Department of Biological Sciences, Faculty of Science, Kuwait University, Kuwait City, Kuwait
Tel +965 2 498 5909
CNR Nanotec, Istituto di Nanotecnologia, Lecce, Italy
Tel +39 0832 319 829
Purpose: Chitosan nanoparticles (CS NPs) have been used as a good vehicle for nano-drug delivery due to their good physicochemical properties. Epigallocatechin-3-gallate (EGCG), one of the major active ingredients of green tea, is a natural antioxidant that helps in reducing and preventing cell damage and fighting cancer, plus providing other benefits. The aim of this study is to optimise the preparation parameters in terms of the physical characteristics and stability in CS/EGCG NPs conjugation.
Results: The conjugation of CS/EGCGNPs was obtained by means of Poloxamer 188. The average CS/EGCG NPs complex was of size 117.8±38.71nm with a surface charge of +67.8±4.38mV and isoelectric point at pH 7.61.
Conclusion: In conclusion, NPs produced were stable at 4°C with nanometric size, good polydispersity, good loading and efficiency, envisaging to be a possible candidate for nano-therapeutic delivery system against hepatic fibrosis.
Keywords: chitosan, EGCG, conjugation, nano-drug delivery